[8-K] Hamilton Lane Incorporated Reports Material Event
Hamilton Lane Incorporated reported an underwriting agreement related to an offering of Class A Common Stock. The filing summarizes customary representations, warranties and indemnification provisions in the Underwriting Agreement and discloses a contractual restriction preventing the company, HLA and a selling stockholder from selling or transferring Class A Common Stock or securities convertible into Class A Common Stock for 45 days after September 2, 2025 without the underwriter's written consent. The offering was made under an effective shelf registration (File No. 333-283233) and a prospectus supplement dated September 2, 2025. The company filed the Underwriting Agreement as Exhibit 1.1 and counsel opinion of Simpson Thacher & Bartlett LLP as Exhibit 5.1.
Hamilton Lane Incorporated ha comunicato un accordo di sottoscrizione relativo a un’offerta di Azioni Ordinarie di Classe A. Il documento riassume le consuete rappresentazioni, garanzie e disposizioni di indennizzo previste dall’Underwriting Agreement e dichiara una limitazione contrattuale che impedisce alla società, a HLA e a un azionista venditore di vendere o trasferire Azioni Ordinarie di Classe A o titoli convertibili in tali azioni per 45 giorni dopo il 2 settembre 2025 senza il consenso scritto del sottoscrittore. L’offerta è stata effettuata ai sensi di una registrazione shelf efficace (File No. 333-283233) e di un supplemento al prospetto datato 2 settembre 2025. La società ha depositato l’Underwriting Agreement come Exhibit 1.1 e il parere legale di Simpson Thacher & Bartlett LLP come Exhibit 5.1.
Hamilton Lane Incorporated informó un acuerdo de suscripción relacionado con una oferta de Acciones Ordinarias Clase A. La presentación resume las habituales declaraciones, garantías y disposiciones de indemnización del Acuerdo de Suscripción y revela una restricción contractual que impide a la compañía, a HLA y a un accionista vendedor vender o transferir Acciones Ordinarias Clase A o valores convertibles en dichas acciones durante 45 días después del 2 de septiembre de 2025 sin el consentimiento por escrito del suscriptor. La oferta se realizó bajo un registro shelf efectivo (File No. 333-283233) y un suplemento de prospecto fechado el 2 de septiembre de 2025. La compañía presentó el Acuerdo de Suscripción como Exhibit 1.1 y el dictamen legal de Simpson Thacher & Bartlett LLP como Exhibit 5.1.
Hamilton Lane Incorporated는 클래스 A 보통주 발행과 관련된 인수계약을 보고했습니다. 제출서류는 인수계약서에 포함된 통상적인 진술·보증 및 면책 조항을 요약하고 있으며, 회사와 HLA 및 매도주주가 인수인의 서면 동의 없이 2025년 9월 2일 이후 45일간 클래스 A 보통주 또는 클래스 A 보통주로 전환 가능한 증권을 매각하거나 양도하지 못하도록 하는 계약상 제한을 공시하고 있습니다. 해당 발행은 유효한 셸프 등록(File No. 333-283233)과 2025년 9월 2일자 투자설명서 보충자료에 따라 이루어졌습니다. 회사는 인수계약을 Exhibit 1.1로, Simpson Thacher & Bartlett LLP의 법률 의견서를 Exhibit 5.1로 제출했습니다.
Hamilton Lane Incorporated a déclaré un contrat de souscription relatif à une offre d’actions ordinaires de catégorie A. Le dossier résume les déclarations, garanties et dispositions d’indemnisation usuelles prévues par l’Underwriting Agreement et divulgue une restriction contractuelle empêchant la société, HLA et un actionnaire vendeur de vendre ou transférer des actions ordinaires de catégorie A ou des titres convertibles en ces actions pendant 45 jours après le 2 septembre 2025 sans le consentement écrit du souscripteur. L’offre a été réalisée dans le cadre d’un enregistrement shelf effectif (File No. 333-283233) et d’un supplément de prospectus daté du 2 septembre 2025. La société a déposé l’Underwriting Agreement en tant qu’Exhibit 1.1 et l’avis juridique de Simpson Thacher & Bartlett LLP en tant qu’Exhibit 5.1.
Hamilton Lane Incorporated meldete einen Übernahmevertrag im Zusammenhang mit einem Angebot von Class-A-Stammaktien. Die Einreichung fasst die üblichen Zusicherungen, Garantien und Entschädigungsregelungen des Underwriting Agreement zusammen und offenbart eine vertragliche Beschränkung, die das Unternehmen, HLA und einen veräußernden Aktionär daran hindert, Class-A-Stammaktien oder in solche Aktien wandelbare Wertpapiere für 45 Tage nach dem 2. September 2025 ohne schriftliche Zustimmung des Underwriters zu verkaufen oder zu übertragen. Das Angebot erfolgte unter einem wirksamen Shelf-Registration (File No. 333-283233) und einem Prospektzusatz vom 2. September 2025. Das Unternehmen reichte das Underwriting Agreement als Exhibit 1.1 und die Stellungnahme der Kanzlei Simpson Thacher & Bartlett LLP als Exhibit 5.1 ein.
- Underwriting Agreement disclosed with customary representations, warranties and indemnification provisions
- 45-day transfer restriction on sales by the company, HLA and a selling stockholder is explicitly disclosed
- Offering executed under an effective shelf registration (File No. 333-283233) with a prospectus supplement dated September 2, 2025
- Counsel opinion filed as Exhibit 5.1 (Simpson Thacher & Bartlett LLP) and Underwriting Agreement filed as Exhibit 1.1
- None.
Insights
TL;DR: Company executed an underwritten offering under an existing shelf with a standard 45-day lock-up; legal opinion and exhibits were filed.
The disclosure describes an underwritten sale of Class A Common Stock made pursuant to an effective shelf registration statement and a prospectus supplement dated September 2, 2025. The Underwriting Agreement contains customary representations, warranties and indemnities and imposes a 45-day resale restriction for the company, HLA and a selling stockholder. Exhibits filed include the Underwriting Agreement (Exhibit 1.1) and counsel opinion (Exhibit 5.1). From a market-disclosure perspective, this is a routine transactional filing providing legal and contractual details rather than financial results.
TL;DR: Governance disclosure covers indemnities and a short lock-up; filings of key exhibits bolster transparency.
The Form 8-K describes the material terms of an underwriting arrangement and explicitly references indemnification provisions and a 45-day restriction on sales by specified parties. The filing also incorporates the shelf registration and prospectus supplement by reference and attaches the counsel opinion as an exhibit, which supports legal sufficiency of the offering documentation. The disclosure focuses on contractual and compliance elements rather than operational or financial changes.
Hamilton Lane Incorporated ha comunicato un accordo di sottoscrizione relativo a un’offerta di Azioni Ordinarie di Classe A. Il documento riassume le consuete rappresentazioni, garanzie e disposizioni di indennizzo previste dall’Underwriting Agreement e dichiara una limitazione contrattuale che impedisce alla società, a HLA e a un azionista venditore di vendere o trasferire Azioni Ordinarie di Classe A o titoli convertibili in tali azioni per 45 giorni dopo il 2 settembre 2025 senza il consenso scritto del sottoscrittore. L’offerta è stata effettuata ai sensi di una registrazione shelf efficace (File No. 333-283233) e di un supplemento al prospetto datato 2 settembre 2025. La società ha depositato l’Underwriting Agreement come Exhibit 1.1 e il parere legale di Simpson Thacher & Bartlett LLP come Exhibit 5.1.
Hamilton Lane Incorporated informó un acuerdo de suscripción relacionado con una oferta de Acciones Ordinarias Clase A. La presentación resume las habituales declaraciones, garantías y disposiciones de indemnización del Acuerdo de Suscripción y revela una restricción contractual que impide a la compañía, a HLA y a un accionista vendedor vender o transferir Acciones Ordinarias Clase A o valores convertibles en dichas acciones durante 45 días después del 2 de septiembre de 2025 sin el consentimiento por escrito del suscriptor. La oferta se realizó bajo un registro shelf efectivo (File No. 333-283233) y un suplemento de prospecto fechado el 2 de septiembre de 2025. La compañía presentó el Acuerdo de Suscripción como Exhibit 1.1 y el dictamen legal de Simpson Thacher & Bartlett LLP como Exhibit 5.1.
Hamilton Lane Incorporated는 클래스 A 보통주 발행과 관련된 인수계약을 보고했습니다. 제출서류는 인수계약서에 포함된 통상적인 진술·보증 및 면책 조항을 요약하고 있으며, 회사와 HLA 및 매도주주가 인수인의 서면 동의 없이 2025년 9월 2일 이후 45일간 클래스 A 보통주 또는 클래스 A 보통주로 전환 가능한 증권을 매각하거나 양도하지 못하도록 하는 계약상 제한을 공시하고 있습니다. 해당 발행은 유효한 셸프 등록(File No. 333-283233)과 2025년 9월 2일자 투자설명서 보충자료에 따라 이루어졌습니다. 회사는 인수계약을 Exhibit 1.1로, Simpson Thacher & Bartlett LLP의 법률 의견서를 Exhibit 5.1로 제출했습니다.
Hamilton Lane Incorporated a déclaré un contrat de souscription relatif à une offre d’actions ordinaires de catégorie A. Le dossier résume les déclarations, garanties et dispositions d’indemnisation usuelles prévues par l’Underwriting Agreement et divulgue une restriction contractuelle empêchant la société, HLA et un actionnaire vendeur de vendre ou transférer des actions ordinaires de catégorie A ou des titres convertibles en ces actions pendant 45 jours après le 2 septembre 2025 sans le consentement écrit du souscripteur. L’offre a été réalisée dans le cadre d’un enregistrement shelf effectif (File No. 333-283233) et d’un supplément de prospectus daté du 2 septembre 2025. La société a déposé l’Underwriting Agreement en tant qu’Exhibit 1.1 et l’avis juridique de Simpson Thacher & Bartlett LLP en tant qu’Exhibit 5.1.
Hamilton Lane Incorporated meldete einen Übernahmevertrag im Zusammenhang mit einem Angebot von Class-A-Stammaktien. Die Einreichung fasst die üblichen Zusicherungen, Garantien und Entschädigungsregelungen des Underwriting Agreement zusammen und offenbart eine vertragliche Beschränkung, die das Unternehmen, HLA und einen veräußernden Aktionär daran hindert, Class-A-Stammaktien oder in solche Aktien wandelbare Wertpapiere für 45 Tage nach dem 2. September 2025 ohne schriftliche Zustimmung des Underwriters zu verkaufen oder zu übertragen. Das Angebot erfolgte unter einem wirksamen Shelf-Registration (File No. 333-283233) und einem Prospektzusatz vom 2. September 2025. Das Unternehmen reichte das Underwriting Agreement als Exhibit 1.1 und die Stellungnahme der Kanzlei Simpson Thacher & Bartlett LLP als Exhibit 5.1 ein.